Jun 04, 2020
Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses
Apr 27, 2020
Valo Therapeutics to Support Development of a Pan - Coronavirus Vaccine
Feb 06, 2020
Valo Therapeutics Announces New Funding for Immuno-Oncology Trials
Jan 13, 2020
DNAtrix Appoints Jeff Knapp as Chief Executive Officer and to Board of Directors
Dec 20, 2019
iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis
Nov 28, 2019
WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products
Nov 24, 2019
DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
Nov 11, 2019
DNAtrix to Present Updated Results from the Phase 2 CAPTIVE / KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
Sep 02, 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Jun 17, 2019
Valo Therapeutics Appoints Michael Stein as Chief Executive Officer
May 28, 2019
Calidi Biotherapeutics Announces A Collaborative Study With The National Institutes Of Health (NIH) On The Therapeutic Potential Of Oncolytic Viruses Delivered By Mesenchymal Stem Cells
Jan 31, 2019
Okogen Initiates Phase 2 Clinical Trial (RUBY) of OKG-0301 in Patients with Acute Adenoviral Conjunctivitis
Nov 13, 2018
DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
Nov 07, 2018
Effectiveness of DNAtrix's DNX-2440 Oncolytic Virus Expressing OX40L in Solid Tumors to be Presented at the 2018 Annual Meeting of the Society for Immunotherapy of Cancer
Nov 01, 2018
Targovax ASA: Third quarter 2018 Results
Oct 25, 2018
Mitra Biotech Advances Development of Next-Generation Cancer Immunotherapies
Oct 24, 2018
Wanaque Center for Nursing & Rehabilitation Statement Regarding Adenovirus Outbreak
Sep 13, 2018
Spotting the Virus: Russian-Canadian Research Development to Increase the Effectiveness of Viral Cancer Therapy
Sep 12, 2018
Targovax Announces Publication of New Oncolytic Virus Data in the Journal of Medical Virology and Cancer Gene Therapy
Jun 11, 2018
Targovax Strengthens Focus on ONCOS Oncolytic Virus Development Program